Intravitreal autologous bone marrow cd34+ cell therapy for ischemic and degenerative retinal disorders: Preliminary phase 1 clinical trial findings

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 1, 2015, Pages 81-89

  Park, Susanna S ^a   Bauer, Gerhard ^b   Abedi, Mehrdad ^c   Pontow, Suzanne ^b   Panorgias, Athanasios ^a   Jonnal, Ravi ^a   Zawadzki, Robert J ^a   Werner, John S ^a   Nolta, Jan ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

OCT; Retinal degeneration; Retinal imaging; Retinal vein occlusion; Stem cells

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; ELECTRORETINOGRAPHY; EYE EXAMINATION; FEMALE; FOLLOW UP; GEOGRAPHIC ATROPHY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; MACULAR DEGENERATION; MALE; OPEN STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 1 CLINICAL TRIAL; PROSPECTIVE STUDY; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA ISCHEMIA; TREATMENT OUTCOME; VERY ELDERLY; VISUAL ACUITY; YOUNG ADULT; BONE MARROW CELL; CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; IMMUNOLOGY; INTRAVITREAL DRUG ADMINISTRATION; ISCHEMIA; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RETINAL DEGENERATION; RETINAL DISEASES;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BONE MARROW CELLS; CELL TRANSPLANTATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; INTRAVITREAL INJECTIONS; ISCHEMIA; MALE; PROSPECTIVE STUDIES; RETINAL DEGENERATION; RETINAL DISEASES; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84920511399     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-15415     Document Type: Article

References (30)

1. Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004;291:1900–1901.
2. Yanuzzi LA. The Retinal Atlas. United Kingdom: Elsevier Saunders; 2010:63–68.
3. Mitchell P, Smithe W, Chang A. Prevalence and association of retinal vein occlusion in Australia: the Blue Mountain Eye Study. Arch Ophthalmol. 1996;114:1243–1247.
4. Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009;27:2126–2135.
5. Hirami Y, Osakada F, Takahashi K, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett. 2009;458:126–131.
6. Cyranoski D. iPS cells in humans. Nat Biotechnol. 2013;31: 775.
7. Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379:713–720.
8. Booth C, Veys P. T cell depletion in paediatric stem cell transplantation. Clin Exp Immunol. 2013;172:139–147.
9. Jakob P, Landmesser U. Current status of cell-based therapy for heart failure. Curr Heart Fail Rep. 2013;10:165–176.
10. Vrtovec B, Poglajen G, Sever M, et al. CD34þstem cell therapy in nonischemic dilated cardiomyopathy patients. Clin Pharmacol Ther. 2013;94:452–458.
11. Patel AN, Geffner L, Vina RF, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg. 2005;130:1631–1638.
12. Rafii S, Meeus S, Dias S, et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin Cell Dev Biol. 2002;13:61–67.
13. Schmeisser A, Strasser RH. Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J Hematother Stem Cell Res. 2002;11:69–79.
14. Zhang QH, She MP. Biological behaviour and role of endothelial progenitor cells in vascular diseases. Chin Med J (Engl). 2007;120:2297–2303.
15. Sheridan CM, Pate S, Hiscott P, Wong D, Pattwell DM, Kent D. Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol. 2009;247:1361–1367.
16. Chang KH, Chan-Ling T, McFarland EL, et al. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci U S A. 2007;104:10595–10600.
17. Otani A, Dorrell MI, Kinder K, et al. Rescue of retinal degeneration by intravitreally injected adult bone marrowderived lineage-negative hematopoietic stem cells. J Clin Invest. 2004;114:765–774.
18. Caballero S, Sengupta N, Afzal A, et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes. 2007;56:960–967.
19. Park SS, Caballero S, Bauer G, et al. Long-term effects of intravitreal injection of GMP-grade bone marrow derived CD34þ Cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2012;53:986–994.
20. Calzi L, Kent DL, Change KH, et al. Labeling of stem cells with monocrystalline iron oxide for tracking and localization by magnetic resonance imaging. Microvasc Res. 2009;78:132–139.
21. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–675.
22. Thevenaz P, Ruttimann UE, Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process. 1998;7:27–41.
23. Zawadzki RJ, Choi SS, Fuller AR, Evans JW, Hamann B, Werner JS. Cellular resolution volumetric in vivo retinal imaging with adaptive optics-optical coherence tomography. Opt Express. 2009;17:4084–4094.
24. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011;31:1207–1214.
25. Jonas JB, Witzens-Harig M, Arseniev L, Ho AD. Intravitreal autologous bone-marrow-derived mononuclear cell transplantation. Acta Ophthalmologica. 2010;88:e131.
26. Kuroda R, Matsumoto T, Kawakami Y, Fukui T, Mifune Y, Kurosaka M. Clinical impact of circulating CD34-positive cells on bone regeneration and healing. Tissue Eng Part B Rev. 2014;20:190–199.
27. Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32:380–389.
28. Masuda H, Asahara T. Clonogenic assay of endothelial progenitor cells. Trends Cardiovasc Med. 2013;23:99–103.
29. Lin CS, Lue TF. Defining vascular stem cells. Stem Cells Dev. 2013;22:1018–1026.
30. McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2010;117:1113–1123.